Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

63.46
-0.6700-1.04%
Post-market: 63.460.00000.00%19:30 EDT
Volume:895.55K
Turnover:56.95M
Market Cap:5.30B
PE:-104.03
High:65.40
Open:64.81
Low:62.80
Close:64.13
52wk High:90.87
52wk Low:61.23
Shares:83.46M
Float Shares:73.65M
Volume Ratio:0.72
T/O Rate:1.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6100
EPS(LYR):7.78
ROE:-7740.12%
ROA:2.46%
PB:-32.03
PE(LYR):8.16

Loading ...

PTC Therapeutics Director Glenn Steele Jr Reports Sale of 12,000 Common Shares Worth $781,920

Reuters
·
16 hours ago

PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 26

PTC Therapeutics is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Sep 22

PTC Therapeutics Acquires Fabry Gene Therapy Candidate ST-920

TIPRANKS
·
Sep 22

PTC Therapeutics Closes Acquisition of the ST-920 Gene Therapy for Fabry Disease

MT Newswires Live
·
Sep 22

PTC Completes Acquisition of St-920 Fabry Disease Gene Therapy

THOMSON REUTERS
·
Sep 22

PTC Therapeutics, - Expects St-920 Bla Submission to FDA Completed in Q4 2026

THOMSON REUTERS
·
Sep 22

Sangamo Exits ST-920 Gene Therapy Assets in Chapter 11 Sale to PTC for USD 111 Million

Reuters
·
Sep 22

PTC Therapeutics Director Michael Schmertzler Disposes of Common Shares Worth $1.34 Million

Reuters
·
Sep 19

PTC Therapeutics upgraded to Outperform from Market Perform at Leerink

TIPRANKS
·
Sep 14

PTC Therapeutics, Inc. : Leerink Partners Assumes Coverage with Outperform vs Market Perform Rating; Target Price $98 vs $70

THOMSON REUTERS
·
Sep 14

PTC Therapeutics Director Michael Schmertzler Disposes of USD 1.35 Million in Common Shares

Reuters
·
Sep 12

Wells Fargo Sticks to Its Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
Sep 02

PTC Therapeutics (PTCT) Stock May Trade Above Fair Value Despite An 81% Run

Simply Wall St.
·
Sep 02

PTC Therapeutics to Buy Drug Candidate from Sangamo for up to $211M

Dow Jones
·
Aug 29

PTC Therapeutics Director Michael Schmertzler Disposes of USD 1.82 Million in Common Shares

Reuters
·
Aug 29

PTC Therapeutics Acquires ST-920 Fabry Gene Therapy Rights

TIPRANKS
·
Aug 29

Broader Sephience PKU Data Could Be A Game Changer For PTC Therapeutics (PTCT)

Simply Wall St.
·
Aug 28

PTC Therapeutics Executives to Speak at Wells Fargo Healthcare Conference

Reuters
·
Aug 27

PTC Therapeutics Reports New Sephience PKU Trial and Real-World Data Showing Sustained Phe Control, Diet Liberalization

Reuters
·
Aug 24